The goal of this study is to evaluate the impact of implementing an AI-enabled clinical workflow tool (Viz COPD) on respiratory specialist follow up and clinical outcomes after an acute exacerbation.
Time perspective: This study will collect data prospectively for the Experimental cohort and retrospectively for the Control cohort. There is also an Exploratory cohort which will collect retrospective and prospective data.
Study Type
OBSERVATIONAL
Enrollment
485
Cooper University Health Care
Cherry Hill, New Jersey, United States
RECRUITINGThomas Jefferson University
Philadelphia, Pennsylvania, United States
RECRUITINGTo assess the effect of a digital health tool implementation on patient follow up with a respiratory specialist within 30 days after discharge for an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
Proportion of patients with a respiratory specialist follow-up visit within 30 days after discharge in the experimental cohort compared to the control cohort.
Time frame: From time of exacerbation to 30 days after discharge
To assess the effect of a digital health tool implementation on time to respiratory specialist follow-up after an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
Time from discharge to respiratory specialist follow-up visit in the experimental cohort compared to the control cohort.
Time frame: Up to 1 year
To assess the effect of a digital health tool implementation on patient follow up with a respiratory specialist within 90 days after discharge for an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
Proportion of patients with a respiratory specialist follow-up visit within 90 days after discharge in the experimental cohort compared to the control cohort.
Time frame: Enrollment to 90 days after discharge
To assess the effect of a digital health tool implementation on readmission following an acute, severe COPD exacerbation.
Proportion of patients with all-cause readmission within 30 days after discharge in the experimental cohort compared to the control cohort.
Time frame: Enrollment to 30 days after discharge
To assess the effect of a digital health tool implementation on readmission following an acute, severe COPD exacerbation.
Proportion of patients with all-cause readmission within 90 days after discharge in the experimental cohort compared to the control cohort.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Time frame: Enrollment to 90 days after discharge
To compare exacerbation rate (moderate, moderate and severe, severe) in the experimental and control cohort after an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
Proportion of patients with an acute exacerbation (moderate, moderate and severe, severe) within 30 days after discharge in the experimental cohort compared to the control cohort
Time frame: Enrollment to 30 days after discharge
To compare exacerbation rate (moderate, moderate and severe, severe) in the experimental and control cohort after an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
Proportion of patients with an acute exacerbation (moderate, moderate and severe, severe) within 90 days after discharge in the experimental cohort compared to the control cohort
Time frame: Enrollment to 90 days post discharge
To compare exacerbation rate (moderate, moderate and severe, severe) in the experimental and control cohort after an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
Rate of acute exacerbations (moderate, moderate and severe, severe) at 1 year after discharge in the experimental cohort compared to the control cohort.
Time frame: Enrollment to 1 year post discharge
To compare healthcare resource utilization in the experimental and control cohort following discharge for an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
Proportion of patients with a composite outcome consisting of emergency department visits, readmissions, or exacerbations within 30 days after discharge in the experimental cohort compared to the control cohort
Time frame: Enrollment through 30 days after discharge
To compare healthcare resource utilization in the experimental and control cohort following discharge for an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
Proportion of patients with a composite outcome consisting of emergency department visits, readmissions, or exacerbations within 90 days after discharge inthe experimental cohort compared to the control cohort.
Time frame: Enrollment through 90 days after discharge
To compare healthcare resource utilization in the experimental and control cohort following discharge for an acute COPD exacerbation resulting in an emergency department visit or hospitalization - 1 year
Rate of a composite outcome consisting of emergency department visits, readmissions, or exacerbations at 1 year after discharge in the experimental cohort compared to the control cohort.
Time frame: Enrollment through 1 year after discharge
To compare the rate of cardiovascular events in the experimental and control cohort after an acute COPD exacerbation resulting in an emergency department visit or hospitalization - 30 days
Proportion of patients with a cardiovascular event within 30 days after discharge in the experimental cohort compared to the control cohort.
Time frame: Enrollment through 30 days after discharge
To compare the rate of cardiovascular events in the experimental and control cohort after an acute COPD exacerbation resulting in an emergency department visit or hospitalization - 1 year
Rate of cardiovascular events at 1 year after discharge in the experimental cohort compared to the control cohort.
Time frame: Enrollment through 1 year after discharge
To compare patient mortality in the experimental and control cohort after an acute COPD exacerbation resulting in an emergency department visit or hospitalization - 30 days
Proportion of patients with allcause mortality within 30 days after discharge in the experimental cohort compared to the control cohort
Time frame: Enrollment through 30 days after discharge
To compare patient mortality in the experimental and control cohort after an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
Proportion of patients with allcause mortality within 90 days after discharge in the experimental cohort compared to the control cohort.
Time frame: Enrollment through 90 days after discharge
To compare patient mortality in the experimental and control cohort after an acute COPD exacerbation resulting in an emergency department visit or hospitalization - 1 year.
Rate of all-cause mortality at 1 year after discharge in the experimental cohort compared to the control cohort.
Time frame: Enrollment through 1 year after discharge
To assess the impact of a digital health tool implementation on achieving pharmacological treatment that is consistent with the GOLD treatment recommendations after an acute COPD exacerbation resulting in an emergency department visit or hospitalization.
The proportion of patients in the experimental cohort with pharmacological treatment consistent with the GOLD treatment recommendations at 30 and 90 days after discharge for the index exacerbation compared to the control cohort.
Time frame: Enrollment through 90 days